Register free now:

Sign Up:

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

Register  

B cell repertoire in determining responses to CHECKPOINT BLOCKADE in NSCLC

Available on demand

LinkedIn icon

Immune-related adverse events following checkpoint blockade are the achilles heel of this revolutionary treatment paradigm in cancer. This poses not only a significant healthcare burden in terms of increased morbidity and mortality to our patients, but also a huge financial and socioeconomic burden. Elucidating the mechanisms underpinning this phenomenon is of key importance to be able to stratify patients at risk of toxicity and improve long-term treatment outcomes.

Key learning objectives

  • Discover the mechanisms of immunotherapy
  • Understand the burden and incidence of immune-related adverse events
  • Review biological mechanisms
  • Explore biomarker research

Who should attend?

  • Researchers, post-docs, scientists, and professors in academia and pharmaceuticals working in the fields of biomarker discovery
  • Those working in patient stratification, therapeutic response prediction and diagnostics, and CDx development for immuno-oncology, autoimmune and neurological diseases

Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

         

          

Speakers:

Presenter
Dr. Akshay Patel
Specialist Registrar in Thoracic Surgery and Clinical Lecturer, Institute of Immunology and Immunotherapy, University of Birmingham
University of Birmingham
View Biography
Presenter
Professor Gary Middleton
Professor of Medical Oncology
University of Birmingham
View Biography
Presenter
Dr. Carrie Haslam
Associate Editor
SelectScience
View Biography
Presenter
Moderator: Lawrence Howes
Editorial Team
SelectScience
View Biography